nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluoxetine—CYP2B6—Ifosfamide—testicular cancer	0.0827	0.131	CbGbCtD
Fluoxetine—CYP3A5—Ifosfamide—testicular cancer	0.0652	0.103	CbGbCtD
Fluoxetine—CYP2C19—Ifosfamide—testicular cancer	0.0526	0.0831	CbGbCtD
Fluoxetine—CYP2C9—Ifosfamide—testicular cancer	0.0437	0.0691	CbGbCtD
Fluoxetine—CYP2B6—Cisplatin—testicular cancer	0.0402	0.0636	CbGbCtD
Fluoxetine—ABCB1—Dactinomycin—testicular cancer	0.0359	0.0568	CbGbCtD
Fluoxetine—CYP3A5—Etoposide—testicular cancer	0.0311	0.0492	CbGbCtD
Fluoxetine—CYP2B6—Doxorubicin—testicular cancer	0.027	0.0426	CbGbCtD
Fluoxetine—ALB—Methotrexate—testicular cancer	0.0256	0.0405	CbGbCtD
Fluoxetine—CYP3A4—Ifosfamide—testicular cancer	0.0254	0.0402	CbGbCtD
Fluoxetine—CYP1A2—Etoposide—testicular cancer	0.0232	0.0366	CbGbCtD
Fluoxetine—ABCB1—Vinblastine—testicular cancer	0.0225	0.0356	CbGbCtD
Fluoxetine—CYP2C9—Cisplatin—testicular cancer	0.0213	0.0336	CbGbCtD
Fluoxetine—CYP2D6—Vinblastine—testicular cancer	0.0212	0.0335	CbGbCtD
Fluoxetine—ABCB1—Cisplatin—testicular cancer	0.0206	0.0326	CbGbCtD
Fluoxetine—ABCB1—Etoposide—testicular cancer	0.0203	0.032	CbGbCtD
Fluoxetine—ABCB1—Doxorubicin—testicular cancer	0.0138	0.0219	CbGbCtD
Fluoxetine—CYP3A4—Vinblastine—testicular cancer	0.0135	0.0213	CbGbCtD
Fluoxetine—ABCB1—Methotrexate—testicular cancer	0.0134	0.0212	CbGbCtD
Fluoxetine—CYP2D6—Doxorubicin—testicular cancer	0.013	0.0206	CbGbCtD
Fluoxetine—CYP3A4—Etoposide—testicular cancer	0.0121	0.0192	CbGbCtD
Fluoxetine—CYP3A4—Doxorubicin—testicular cancer	0.00828	0.0131	CbGbCtD
Fluoxetine—Sinusitis—Epirubicin—testicular cancer	0.000124	0.000337	CcSEcCtD
Fluoxetine—Feeling abnormal—Etoposide—testicular cancer	0.000124	0.000337	CcSEcCtD
Fluoxetine—Hyperglycaemia—Doxorubicin—testicular cancer	0.000123	0.000336	CcSEcCtD
Fluoxetine—Nausea—Dactinomycin—testicular cancer	0.000123	0.000335	CcSEcCtD
Fluoxetine—Pneumonia—Doxorubicin—testicular cancer	0.000123	0.000334	CcSEcCtD
Fluoxetine—Gastrointestinal pain—Etoposide—testicular cancer	0.000123	0.000334	CcSEcCtD
Fluoxetine—Drowsiness—Doxorubicin—testicular cancer	0.000122	0.000332	CcSEcCtD
Fluoxetine—Visual impairment—Methotrexate—testicular cancer	0.000122	0.000332	CcSEcCtD
Fluoxetine—Stevens-Johnson syndrome—Doxorubicin—testicular cancer	0.000121	0.000329	CcSEcCtD
Fluoxetine—Vomiting—Ifosfamide—testicular cancer	0.000121	0.000329	CcSEcCtD
Fluoxetine—Hypersensitivity—Cisplatin—testicular cancer	0.000121	0.000328	CcSEcCtD
Fluoxetine—Bradycardia—Epirubicin—testicular cancer	0.000121	0.000328	CcSEcCtD
Fluoxetine—Renal failure—Doxorubicin—testicular cancer	0.00012	0.000326	CcSEcCtD
Fluoxetine—Rash—Ifosfamide—testicular cancer	0.00012	0.000326	CcSEcCtD
Fluoxetine—Dermatitis—Ifosfamide—testicular cancer	0.00012	0.000326	CcSEcCtD
Fluoxetine—Erythema multiforme—Methotrexate—testicular cancer	0.00012	0.000326	CcSEcCtD
Fluoxetine—Neuropathy peripheral—Doxorubicin—testicular cancer	0.00012	0.000326	CcSEcCtD
Fluoxetine—Urticaria—Etoposide—testicular cancer	0.000119	0.000324	CcSEcCtD
Fluoxetine—Haemoglobin—Epirubicin—testicular cancer	0.000119	0.000324	CcSEcCtD
Fluoxetine—Stomatitis—Doxorubicin—testicular cancer	0.000119	0.000324	CcSEcCtD
Fluoxetine—Jaundice—Doxorubicin—testicular cancer	0.000119	0.000324	CcSEcCtD
Fluoxetine—Rhinitis—Epirubicin—testicular cancer	0.000119	0.000323	CcSEcCtD
Fluoxetine—Abdominal pain—Etoposide—testicular cancer	0.000119	0.000323	CcSEcCtD
Fluoxetine—Body temperature increased—Etoposide—testicular cancer	0.000119	0.000323	CcSEcCtD
Fluoxetine—Urinary tract infection—Doxorubicin—testicular cancer	0.000119	0.000323	CcSEcCtD
Fluoxetine—Conjunctivitis—Doxorubicin—testicular cancer	0.000119	0.000323	CcSEcCtD
Fluoxetine—Hepatitis—Epirubicin—testicular cancer	0.000118	0.000322	CcSEcCtD
Fluoxetine—Haemorrhage—Epirubicin—testicular cancer	0.000118	0.000322	CcSEcCtD
Fluoxetine—Tinnitus—Methotrexate—testicular cancer	0.000118	0.000321	CcSEcCtD
Fluoxetine—Hypoaesthesia—Epirubicin—testicular cancer	0.000118	0.000321	CcSEcCtD
Fluoxetine—Asthenia—Cisplatin—testicular cancer	0.000118	0.00032	CcSEcCtD
Fluoxetine—Pharyngitis—Epirubicin—testicular cancer	0.000118	0.00032	CcSEcCtD
Fluoxetine—Sweating—Doxorubicin—testicular cancer	0.000117	0.000318	CcSEcCtD
Fluoxetine—Oedema peripheral—Epirubicin—testicular cancer	0.000117	0.000317	CcSEcCtD
Fluoxetine—Haematuria—Doxorubicin—testicular cancer	0.000116	0.000317	CcSEcCtD
Fluoxetine—Epistaxis—Doxorubicin—testicular cancer	0.000115	0.000313	CcSEcCtD
Fluoxetine—Sinusitis—Doxorubicin—testicular cancer	0.000115	0.000312	CcSEcCtD
Fluoxetine—Visual impairment—Epirubicin—testicular cancer	0.000114	0.000311	CcSEcCtD
Fluoxetine—Chills—Methotrexate—testicular cancer	0.000114	0.000309	CcSEcCtD
Fluoxetine—Nausea—Ifosfamide—testicular cancer	0.000113	0.000307	CcSEcCtD
Fluoxetine—Diarrhoea—Cisplatin—testicular cancer	0.000112	0.000305	CcSEcCtD
Fluoxetine—Erythema multiforme—Epirubicin—testicular cancer	0.000112	0.000305	CcSEcCtD
Fluoxetine—Alopecia—Methotrexate—testicular cancer	0.000112	0.000304	CcSEcCtD
Fluoxetine—Bradycardia—Doxorubicin—testicular cancer	0.000112	0.000304	CcSEcCtD
Fluoxetine—Mental disorder—Methotrexate—testicular cancer	0.000111	0.000302	CcSEcCtD
Fluoxetine—Hypersensitivity—Etoposide—testicular cancer	0.000111	0.000301	CcSEcCtD
Fluoxetine—Tinnitus—Epirubicin—testicular cancer	0.00011	0.0003	CcSEcCtD
Fluoxetine—Malnutrition—Methotrexate—testicular cancer	0.00011	0.0003	CcSEcCtD
Fluoxetine—Haemoglobin—Doxorubicin—testicular cancer	0.00011	0.0003	CcSEcCtD
Fluoxetine—Rhinitis—Doxorubicin—testicular cancer	0.00011	0.000299	CcSEcCtD
Fluoxetine—Haemorrhage—Doxorubicin—testicular cancer	0.00011	0.000298	CcSEcCtD
Fluoxetine—Hepatitis—Doxorubicin—testicular cancer	0.00011	0.000298	CcSEcCtD
Fluoxetine—Hypoaesthesia—Doxorubicin—testicular cancer	0.000109	0.000297	CcSEcCtD
Fluoxetine—Pharyngitis—Doxorubicin—testicular cancer	0.000109	0.000296	CcSEcCtD
Fluoxetine—Oedema peripheral—Doxorubicin—testicular cancer	0.000108	0.000294	CcSEcCtD
Fluoxetine—Dysgeusia—Methotrexate—testicular cancer	0.000108	0.000294	CcSEcCtD
Fluoxetine—Asthenia—Etoposide—testicular cancer	0.000108	0.000293	CcSEcCtD
Fluoxetine—Back pain—Methotrexate—testicular cancer	0.000107	0.00029	CcSEcCtD
Fluoxetine—Chills—Epirubicin—testicular cancer	0.000106	0.000289	CcSEcCtD
Fluoxetine—Pruritus—Etoposide—testicular cancer	0.000106	0.000289	CcSEcCtD
Fluoxetine—Arrhythmia—Epirubicin—testicular cancer	0.000106	0.000288	CcSEcCtD
Fluoxetine—Visual impairment—Doxorubicin—testicular cancer	0.000106	0.000287	CcSEcCtD
Fluoxetine—Alopecia—Epirubicin—testicular cancer	0.000105	0.000285	CcSEcCtD
Fluoxetine—Vomiting—Cisplatin—testicular cancer	0.000104	0.000283	CcSEcCtD
Fluoxetine—Mental disorder—Epirubicin—testicular cancer	0.000104	0.000282	CcSEcCtD
Fluoxetine—Erythema multiforme—Doxorubicin—testicular cancer	0.000104	0.000282	CcSEcCtD
Fluoxetine—Rash—Cisplatin—testicular cancer	0.000103	0.000281	CcSEcCtD
Fluoxetine—Dermatitis—Cisplatin—testicular cancer	0.000103	0.000281	CcSEcCtD
Fluoxetine—Malnutrition—Epirubicin—testicular cancer	0.000103	0.00028	CcSEcCtD
Fluoxetine—Diarrhoea—Etoposide—testicular cancer	0.000103	0.000279	CcSEcCtD
Fluoxetine—Ill-defined disorder—Methotrexate—testicular cancer	0.000102	0.000278	CcSEcCtD
Fluoxetine—Tinnitus—Doxorubicin—testicular cancer	0.000102	0.000278	CcSEcCtD
Fluoxetine—Anaemia—Methotrexate—testicular cancer	0.000102	0.000277	CcSEcCtD
Fluoxetine—Flatulence—Epirubicin—testicular cancer	0.000102	0.000276	CcSEcCtD
Fluoxetine—Tension—Epirubicin—testicular cancer	0.000101	0.000275	CcSEcCtD
Fluoxetine—Dysgeusia—Epirubicin—testicular cancer	0.000101	0.000275	CcSEcCtD
Fluoxetine—Nervousness—Epirubicin—testicular cancer	0.0001	0.000272	CcSEcCtD
Fluoxetine—Back pain—Epirubicin—testicular cancer	9.97e-05	0.000271	CcSEcCtD
Fluoxetine—Malaise—Methotrexate—testicular cancer	9.93e-05	0.00027	CcSEcCtD
Fluoxetine—Dizziness—Etoposide—testicular cancer	9.93e-05	0.00027	CcSEcCtD
Fluoxetine—Muscle spasms—Epirubicin—testicular cancer	9.91e-05	0.00027	CcSEcCtD
Fluoxetine—Vertigo—Methotrexate—testicular cancer	9.9e-05	0.000269	CcSEcCtD
Fluoxetine—Leukopenia—Methotrexate—testicular cancer	9.86e-05	0.000268	CcSEcCtD
Fluoxetine—Chills—Doxorubicin—testicular cancer	9.83e-05	0.000268	CcSEcCtD
Fluoxetine—Arrhythmia—Doxorubicin—testicular cancer	9.79e-05	0.000266	CcSEcCtD
Fluoxetine—Nausea—Cisplatin—testicular cancer	9.73e-05	0.000265	CcSEcCtD
Fluoxetine—Alopecia—Doxorubicin—testicular cancer	9.68e-05	0.000263	CcSEcCtD
Fluoxetine—Cough—Methotrexate—testicular cancer	9.61e-05	0.000262	CcSEcCtD
Fluoxetine—Mental disorder—Doxorubicin—testicular cancer	9.6e-05	0.000261	CcSEcCtD
Fluoxetine—Ill-defined disorder—Epirubicin—testicular cancer	9.57e-05	0.00026	CcSEcCtD
Fluoxetine—Convulsion—Methotrexate—testicular cancer	9.55e-05	0.00026	CcSEcCtD
Fluoxetine—Vomiting—Etoposide—testicular cancer	9.54e-05	0.00026	CcSEcCtD
Fluoxetine—Malnutrition—Doxorubicin—testicular cancer	9.54e-05	0.00026	CcSEcCtD
Fluoxetine—Anaemia—Epirubicin—testicular cancer	9.53e-05	0.000259	CcSEcCtD
Fluoxetine—Agitation—Epirubicin—testicular cancer	9.47e-05	0.000258	CcSEcCtD
Fluoxetine—Rash—Etoposide—testicular cancer	9.46e-05	0.000257	CcSEcCtD
Fluoxetine—Dermatitis—Etoposide—testicular cancer	9.46e-05	0.000257	CcSEcCtD
Fluoxetine—Headache—Etoposide—testicular cancer	9.4e-05	0.000256	CcSEcCtD
Fluoxetine—Flatulence—Doxorubicin—testicular cancer	9.4e-05	0.000256	CcSEcCtD
Fluoxetine—Myalgia—Methotrexate—testicular cancer	9.38e-05	0.000255	CcSEcCtD
Fluoxetine—Chest pain—Methotrexate—testicular cancer	9.38e-05	0.000255	CcSEcCtD
Fluoxetine—Arthralgia—Methotrexate—testicular cancer	9.38e-05	0.000255	CcSEcCtD
Fluoxetine—Tension—Doxorubicin—testicular cancer	9.36e-05	0.000255	CcSEcCtD
Fluoxetine—Dysgeusia—Doxorubicin—testicular cancer	9.34e-05	0.000254	CcSEcCtD
Fluoxetine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—testicular cancer	9.31e-05	0.000253	CcSEcCtD
Fluoxetine—Malaise—Epirubicin—testicular cancer	9.3e-05	0.000253	CcSEcCtD
Fluoxetine—Discomfort—Methotrexate—testicular cancer	9.27e-05	0.000252	CcSEcCtD
Fluoxetine—Nervousness—Doxorubicin—testicular cancer	9.27e-05	0.000252	CcSEcCtD
Fluoxetine—Vertigo—Epirubicin—testicular cancer	9.26e-05	0.000252	CcSEcCtD
Fluoxetine—Syncope—Epirubicin—testicular cancer	9.25e-05	0.000252	CcSEcCtD
Fluoxetine—Leukopenia—Epirubicin—testicular cancer	9.23e-05	0.000251	CcSEcCtD
Fluoxetine—Back pain—Doxorubicin—testicular cancer	9.23e-05	0.000251	CcSEcCtD
Fluoxetine—Muscle spasms—Doxorubicin—testicular cancer	9.17e-05	0.00025	CcSEcCtD
Fluoxetine—Palpitations—Epirubicin—testicular cancer	9.11e-05	0.000248	CcSEcCtD
Fluoxetine—Confusional state—Methotrexate—testicular cancer	9.07e-05	0.000247	CcSEcCtD
Fluoxetine—Loss of consciousness—Epirubicin—testicular cancer	9.06e-05	0.000247	CcSEcCtD
Fluoxetine—Cough—Epirubicin—testicular cancer	9e-05	0.000245	CcSEcCtD
Fluoxetine—Anaphylactic shock—Methotrexate—testicular cancer	8.99e-05	0.000245	CcSEcCtD
Fluoxetine—Convulsion—Epirubicin—testicular cancer	8.93e-05	0.000243	CcSEcCtD
Fluoxetine—Infection—Methotrexate—testicular cancer	8.93e-05	0.000243	CcSEcCtD
Fluoxetine—Nausea—Etoposide—testicular cancer	8.92e-05	0.000243	CcSEcCtD
Fluoxetine—Hypertension—Epirubicin—testicular cancer	8.9e-05	0.000242	CcSEcCtD
Fluoxetine—Ill-defined disorder—Doxorubicin—testicular cancer	8.85e-05	0.000241	CcSEcCtD
Fluoxetine—Anaemia—Doxorubicin—testicular cancer	8.82e-05	0.00024	CcSEcCtD
Fluoxetine—Thrombocytopenia—Methotrexate—testicular cancer	8.8e-05	0.00024	CcSEcCtD
Fluoxetine—Chest pain—Epirubicin—testicular cancer	8.78e-05	0.000239	CcSEcCtD
Fluoxetine—Arthralgia—Epirubicin—testicular cancer	8.78e-05	0.000239	CcSEcCtD
Fluoxetine—Myalgia—Epirubicin—testicular cancer	8.78e-05	0.000239	CcSEcCtD
Fluoxetine—Agitation—Doxorubicin—testicular cancer	8.77e-05	0.000239	CcSEcCtD
Fluoxetine—Anxiety—Epirubicin—testicular cancer	8.75e-05	0.000238	CcSEcCtD
Fluoxetine—Skin disorder—Methotrexate—testicular cancer	8.73e-05	0.000238	CcSEcCtD
Fluoxetine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—testicular cancer	8.72e-05	0.000237	CcSEcCtD
Fluoxetine—Hyperhidrosis—Methotrexate—testicular cancer	8.69e-05	0.000236	CcSEcCtD
Fluoxetine—Discomfort—Epirubicin—testicular cancer	8.67e-05	0.000236	CcSEcCtD
Fluoxetine—Malaise—Doxorubicin—testicular cancer	8.6e-05	0.000234	CcSEcCtD
Fluoxetine—Dry mouth—Epirubicin—testicular cancer	8.58e-05	0.000234	CcSEcCtD
Fluoxetine—Vertigo—Doxorubicin—testicular cancer	8.57e-05	0.000233	CcSEcCtD
Fluoxetine—Anorexia—Methotrexate—testicular cancer	8.57e-05	0.000233	CcSEcCtD
Fluoxetine—Syncope—Doxorubicin—testicular cancer	8.55e-05	0.000233	CcSEcCtD
Fluoxetine—Leukopenia—Doxorubicin—testicular cancer	8.54e-05	0.000232	CcSEcCtD
Fluoxetine—Confusional state—Epirubicin—testicular cancer	8.48e-05	0.000231	CcSEcCtD
Fluoxetine—Palpitations—Doxorubicin—testicular cancer	8.43e-05	0.000229	CcSEcCtD
Fluoxetine—Anaphylactic shock—Epirubicin—testicular cancer	8.41e-05	0.000229	CcSEcCtD
Fluoxetine—Hypotension—Methotrexate—testicular cancer	8.4e-05	0.000229	CcSEcCtD
Fluoxetine—Loss of consciousness—Doxorubicin—testicular cancer	8.38e-05	0.000228	CcSEcCtD
Fluoxetine—Infection—Epirubicin—testicular cancer	8.36e-05	0.000227	CcSEcCtD
Fluoxetine—Cough—Doxorubicin—testicular cancer	8.32e-05	0.000226	CcSEcCtD
Fluoxetine—Shock—Epirubicin—testicular cancer	8.28e-05	0.000225	CcSEcCtD
Fluoxetine—Convulsion—Doxorubicin—testicular cancer	8.27e-05	0.000225	CcSEcCtD
Fluoxetine—Thrombocytopenia—Epirubicin—testicular cancer	8.24e-05	0.000224	CcSEcCtD
Fluoxetine—Hypertension—Doxorubicin—testicular cancer	8.24e-05	0.000224	CcSEcCtD
Fluoxetine—Tachycardia—Epirubicin—testicular cancer	8.21e-05	0.000223	CcSEcCtD
Fluoxetine—Musculoskeletal discomfort—Methotrexate—testicular cancer	8.19e-05	0.000223	CcSEcCtD
Fluoxetine—Skin disorder—Epirubicin—testicular cancer	8.17e-05	0.000222	CcSEcCtD
Fluoxetine—Hyperhidrosis—Epirubicin—testicular cancer	8.13e-05	0.000221	CcSEcCtD
Fluoxetine—Insomnia—Methotrexate—testicular cancer	8.13e-05	0.000221	CcSEcCtD
Fluoxetine—Arthralgia—Doxorubicin—testicular cancer	8.12e-05	0.000221	CcSEcCtD
Fluoxetine—Chest pain—Doxorubicin—testicular cancer	8.12e-05	0.000221	CcSEcCtD
Fluoxetine—Myalgia—Doxorubicin—testicular cancer	8.12e-05	0.000221	CcSEcCtD
Fluoxetine—Anxiety—Doxorubicin—testicular cancer	8.09e-05	0.00022	CcSEcCtD
Fluoxetine—Paraesthesia—Methotrexate—testicular cancer	8.07e-05	0.00022	CcSEcCtD
Fluoxetine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—testicular cancer	8.07e-05	0.000219	CcSEcCtD
Fluoxetine—Discomfort—Doxorubicin—testicular cancer	8.02e-05	0.000218	CcSEcCtD
Fluoxetine—Anorexia—Epirubicin—testicular cancer	8.02e-05	0.000218	CcSEcCtD
Fluoxetine—Dyspnoea—Methotrexate—testicular cancer	8.02e-05	0.000218	CcSEcCtD
Fluoxetine—Somnolence—Methotrexate—testicular cancer	7.99e-05	0.000217	CcSEcCtD
Fluoxetine—Dry mouth—Doxorubicin—testicular cancer	7.94e-05	0.000216	CcSEcCtD
Fluoxetine—Dyspepsia—Methotrexate—testicular cancer	7.91e-05	0.000215	CcSEcCtD
Fluoxetine—Hypotension—Epirubicin—testicular cancer	7.86e-05	0.000214	CcSEcCtD
Fluoxetine—Confusional state—Doxorubicin—testicular cancer	7.85e-05	0.000214	CcSEcCtD
Fluoxetine—Decreased appetite—Methotrexate—testicular cancer	7.82e-05	0.000213	CcSEcCtD
Fluoxetine—Anaphylactic shock—Doxorubicin—testicular cancer	7.79e-05	0.000212	CcSEcCtD
Fluoxetine—Gastrointestinal disorder—Methotrexate—testicular cancer	7.76e-05	0.000211	CcSEcCtD
Fluoxetine—Fatigue—Methotrexate—testicular cancer	7.75e-05	0.000211	CcSEcCtD
Fluoxetine—Infection—Doxorubicin—testicular cancer	7.73e-05	0.00021	CcSEcCtD
Fluoxetine—Pain—Methotrexate—testicular cancer	7.69e-05	0.000209	CcSEcCtD
Fluoxetine—Musculoskeletal discomfort—Epirubicin—testicular cancer	7.67e-05	0.000209	CcSEcCtD
Fluoxetine—Shock—Doxorubicin—testicular cancer	7.66e-05	0.000208	CcSEcCtD
Fluoxetine—Thrombocytopenia—Doxorubicin—testicular cancer	7.62e-05	0.000207	CcSEcCtD
Fluoxetine—Insomnia—Epirubicin—testicular cancer	7.61e-05	0.000207	CcSEcCtD
Fluoxetine—Tachycardia—Doxorubicin—testicular cancer	7.6e-05	0.000207	CcSEcCtD
Fluoxetine—Skin disorder—Doxorubicin—testicular cancer	7.56e-05	0.000206	CcSEcCtD
Fluoxetine—Paraesthesia—Epirubicin—testicular cancer	7.56e-05	0.000206	CcSEcCtD
Fluoxetine—Hyperhidrosis—Doxorubicin—testicular cancer	7.53e-05	0.000205	CcSEcCtD
Fluoxetine—Dyspnoea—Epirubicin—testicular cancer	7.5e-05	0.000204	CcSEcCtD
Fluoxetine—Somnolence—Epirubicin—testicular cancer	7.48e-05	0.000204	CcSEcCtD
Fluoxetine—Anorexia—Doxorubicin—testicular cancer	7.42e-05	0.000202	CcSEcCtD
Fluoxetine—Feeling abnormal—Methotrexate—testicular cancer	7.41e-05	0.000202	CcSEcCtD
Fluoxetine—Dyspepsia—Epirubicin—testicular cancer	7.41e-05	0.000202	CcSEcCtD
Fluoxetine—Gastrointestinal pain—Methotrexate—testicular cancer	7.35e-05	0.0002	CcSEcCtD
Fluoxetine—Decreased appetite—Epirubicin—testicular cancer	7.31e-05	0.000199	CcSEcCtD
Fluoxetine—Hypotension—Doxorubicin—testicular cancer	7.27e-05	0.000198	CcSEcCtD
Fluoxetine—Gastrointestinal disorder—Epirubicin—testicular cancer	7.26e-05	0.000198	CcSEcCtD
Fluoxetine—Fatigue—Epirubicin—testicular cancer	7.25e-05	0.000197	CcSEcCtD
Fluoxetine—Constipation—Epirubicin—testicular cancer	7.2e-05	0.000196	CcSEcCtD
Fluoxetine—Pain—Epirubicin—testicular cancer	7.2e-05	0.000196	CcSEcCtD
Fluoxetine—Urticaria—Methotrexate—testicular cancer	7.14e-05	0.000194	CcSEcCtD
Fluoxetine—Body temperature increased—Methotrexate—testicular cancer	7.11e-05	0.000193	CcSEcCtD
Fluoxetine—Abdominal pain—Methotrexate—testicular cancer	7.11e-05	0.000193	CcSEcCtD
Fluoxetine—Musculoskeletal discomfort—Doxorubicin—testicular cancer	7.09e-05	0.000193	CcSEcCtD
Fluoxetine—Insomnia—Doxorubicin—testicular cancer	7.04e-05	0.000192	CcSEcCtD
Fluoxetine—Paraesthesia—Doxorubicin—testicular cancer	6.99e-05	0.00019	CcSEcCtD
Fluoxetine—Dyspnoea—Doxorubicin—testicular cancer	6.94e-05	0.000189	CcSEcCtD
Fluoxetine—Feeling abnormal—Epirubicin—testicular cancer	6.93e-05	0.000189	CcSEcCtD
Fluoxetine—Somnolence—Doxorubicin—testicular cancer	6.92e-05	0.000188	CcSEcCtD
Fluoxetine—Gastrointestinal pain—Epirubicin—testicular cancer	6.88e-05	0.000187	CcSEcCtD
Fluoxetine—Dyspepsia—Doxorubicin—testicular cancer	6.85e-05	0.000186	CcSEcCtD
Fluoxetine—Decreased appetite—Doxorubicin—testicular cancer	6.77e-05	0.000184	CcSEcCtD
Fluoxetine—Gastrointestinal disorder—Doxorubicin—testicular cancer	6.72e-05	0.000183	CcSEcCtD
Fluoxetine—Fatigue—Doxorubicin—testicular cancer	6.71e-05	0.000183	CcSEcCtD
Fluoxetine—Urticaria—Epirubicin—testicular cancer	6.68e-05	0.000182	CcSEcCtD
Fluoxetine—Pain—Doxorubicin—testicular cancer	6.66e-05	0.000181	CcSEcCtD
Fluoxetine—Constipation—Doxorubicin—testicular cancer	6.66e-05	0.000181	CcSEcCtD
Fluoxetine—Body temperature increased—Epirubicin—testicular cancer	6.65e-05	0.000181	CcSEcCtD
Fluoxetine—Abdominal pain—Epirubicin—testicular cancer	6.65e-05	0.000181	CcSEcCtD
Fluoxetine—Hypersensitivity—Methotrexate—testicular cancer	6.62e-05	0.00018	CcSEcCtD
Fluoxetine—Asthenia—Methotrexate—testicular cancer	6.45e-05	0.000176	CcSEcCtD
Fluoxetine—Feeling abnormal—Doxorubicin—testicular cancer	6.42e-05	0.000175	CcSEcCtD
Fluoxetine—Gastrointestinal pain—Doxorubicin—testicular cancer	6.37e-05	0.000173	CcSEcCtD
Fluoxetine—Pruritus—Methotrexate—testicular cancer	6.36e-05	0.000173	CcSEcCtD
Fluoxetine—Hypersensitivity—Epirubicin—testicular cancer	6.2e-05	0.000169	CcSEcCtD
Fluoxetine—Urticaria—Doxorubicin—testicular cancer	6.18e-05	0.000168	CcSEcCtD
Fluoxetine—Abdominal pain—Doxorubicin—testicular cancer	6.15e-05	0.000167	CcSEcCtD
Fluoxetine—Body temperature increased—Doxorubicin—testicular cancer	6.15e-05	0.000167	CcSEcCtD
Fluoxetine—Diarrhoea—Methotrexate—testicular cancer	6.15e-05	0.000167	CcSEcCtD
Fluoxetine—Asthenia—Epirubicin—testicular cancer	6.04e-05	0.000164	CcSEcCtD
Fluoxetine—Pruritus—Epirubicin—testicular cancer	5.95e-05	0.000162	CcSEcCtD
Fluoxetine—Dizziness—Methotrexate—testicular cancer	5.95e-05	0.000162	CcSEcCtD
Fluoxetine—Diarrhoea—Epirubicin—testicular cancer	5.76e-05	0.000157	CcSEcCtD
Fluoxetine—Hypersensitivity—Doxorubicin—testicular cancer	5.74e-05	0.000156	CcSEcCtD
Fluoxetine—Vomiting—Methotrexate—testicular cancer	5.72e-05	0.000156	CcSEcCtD
Fluoxetine—Rash—Methotrexate—testicular cancer	5.67e-05	0.000154	CcSEcCtD
Fluoxetine—Dermatitis—Methotrexate—testicular cancer	5.66e-05	0.000154	CcSEcCtD
Fluoxetine—Headache—Methotrexate—testicular cancer	5.63e-05	0.000153	CcSEcCtD
Fluoxetine—Asthenia—Doxorubicin—testicular cancer	5.59e-05	0.000152	CcSEcCtD
Fluoxetine—Dizziness—Epirubicin—testicular cancer	5.56e-05	0.000151	CcSEcCtD
Fluoxetine—Pruritus—Doxorubicin—testicular cancer	5.51e-05	0.00015	CcSEcCtD
Fluoxetine—Vomiting—Epirubicin—testicular cancer	5.35e-05	0.000146	CcSEcCtD
Fluoxetine—Nausea—Methotrexate—testicular cancer	5.34e-05	0.000145	CcSEcCtD
Fluoxetine—Diarrhoea—Doxorubicin—testicular cancer	5.33e-05	0.000145	CcSEcCtD
Fluoxetine—Rash—Epirubicin—testicular cancer	5.31e-05	0.000144	CcSEcCtD
Fluoxetine—Dermatitis—Epirubicin—testicular cancer	5.3e-05	0.000144	CcSEcCtD
Fluoxetine—Headache—Epirubicin—testicular cancer	5.27e-05	0.000143	CcSEcCtD
Fluoxetine—Dizziness—Doxorubicin—testicular cancer	5.15e-05	0.00014	CcSEcCtD
Fluoxetine—Nausea—Epirubicin—testicular cancer	5e-05	0.000136	CcSEcCtD
Fluoxetine—Vomiting—Doxorubicin—testicular cancer	4.95e-05	0.000135	CcSEcCtD
Fluoxetine—Rash—Doxorubicin—testicular cancer	4.91e-05	0.000134	CcSEcCtD
Fluoxetine—Dermatitis—Doxorubicin—testicular cancer	4.9e-05	0.000133	CcSEcCtD
Fluoxetine—Headache—Doxorubicin—testicular cancer	4.88e-05	0.000133	CcSEcCtD
Fluoxetine—Nausea—Doxorubicin—testicular cancer	4.62e-05	0.000126	CcSEcCtD
